In conclusion, the data and insights gained from the STING GOF mice model could therefore be of key importance for the follow-up of patients receiving HCT, immunosuppression, or CAR-T cell therapy for T cell malignancies, as well as for a better comprehension of potential T cell exhaustion in lymphopenic murine models. The gene discussed is STING1; the disease is cancer.